Literature DB >> 14713715

Immune tolerance to myelin proteins.

Audrey Seamons1, Antoine Perchellet, Joan Goverman.   

Abstract

Multiple sclerosis (MS) is a demyelinating disorder of the central nervous system. It is believed to be an autoimmune disease arising from a breakdown of immune tolerance in T cells specific for myelin antigens. The heterogeneity in clinical signs and pathology observed in MS patients suggests a complex pathogenesis in which the specificity of the pathogenic T cells and the tolerance mechanisms that are compromised vary among individual patients. In this review, we summarize some of the features of the diverse immune pathology observed in MS and the animal models used to study this disease. We then describe the current state of knowledge regarding the expression of the major myelin protein antigens believed to be targeted in MS and the mechanisms of immune tolerance that operate on T cells that recognize these antigens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14713715     DOI: 10.1385/IR:28:3:201

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  130 in total

Review 1.  Specificity of autoantibodies to epitopes of myelin proteins in multiple sclerosis.

Authors:  Permphan Dharmasaroja
Journal:  J Neurol Sci       Date:  2003-01-15       Impact factor: 3.181

2.  Compact myelin exists in the absence of basic protein in the shiverer mutant mouse.

Authors:  D A Kirschner; A L Ganser
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

3.  Golli-MBP proteins mark the earliest stages of fiber extension and terminal arboration in the mouse peripheral nervous system.

Authors:  C F Landry; J Ellison; E Skinner; A T Campagnoni
Journal:  J Neurosci Res       Date:  1997-10-15       Impact factor: 4.164

4.  Identification of a new exon in the myelin proteolipid protein gene encoding novel protein isoforms that are restricted to the somata of oligodendrocytes and neurons.

Authors:  E R Bongarzone; C W Campagnoni; K Kampf; E C Jacobs; V W Handley; V Schonmann; A T Campagnoni
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

5.  Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response.

Authors:  A Stefferl; U Brehm; M Storch; D Lambracht-Washington; C Bourquin; K Wonigeit; H Lassmann; C Linington
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

6.  Encephalitogenicity of myelin-associated oligodendrocytic basic protein and 2',3'-cyclic nucleotide 3'-phosphodiesterase for BALB/c and SJL mice.

Authors:  J A Määttä; M S Käldman; S Sakoda; A A Salmi; A E Hinkkanen
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

7.  B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization.

Authors:  P Hjelmström; A E Juedes; J Fjell; N H Ruddle
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

8.  Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.

Authors:  P S Ohashi; S Oehen; K Buerki; H Pircher; C T Ohashi; B Odermatt; B Malissen; R M Zinkernagel; H Hengartner
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

Review 9.  Tolerance and autoimmunity in TCR transgenic mice specific for myelin basic protein.

Authors:  J Goverman
Journal:  Immunol Rev       Date:  1999-06       Impact factor: 12.988

10.  Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.

Authors:  K W Wucherpfennig; A Sette; S Southwood; C Oseroff; M Matsui; J L Strominger; D A Hafler
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  8 in total

1.  Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice.

Authors:  Kazuyuki Kawamura; Katherine A McLaughlin; Robert Weissert; Thomas G Forsthuber
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

2.  Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs.

Authors:  Stefan Lüth; Samuel Huber; Christoph Schramm; Thorsten Buch; Stefan Zander; Christine Stadelmann; Wolfgang Brück; David C Wraith; Johannes Herkel; Ansgar W Lohse
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

3.  Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.

Authors:  Marina Zafranskaya; Patrick Oschmann; Rosel Engel; Andreas Weishaupt; Johannes M van Noort; Hassan Jomaa; Matthias Eberl
Journal:  Immunology       Date:  2006-12-18       Impact factor: 7.397

4.  Proof of Principle for a T Lymphocyte Intrinsic Function of Coronin 1A.

Authors:  Kerstin Siegmund; Victoria Klepsch; Natascha Hermann-Kleiter; Gottfried Baier
Journal:  J Biol Chem       Date:  2016-08-26       Impact factor: 5.157

Review 5.  Autoimmune T cell responses in the central nervous system.

Authors:  Joan Goverman
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

6.  The postnatal maternal environment affects autoimmune disease susceptibility in A/J mice.

Authors:  Laure K Case; Roxana Del Rio; Elizabeth A Bonney; James F Zachary; Elizabeth P Blankenhorn; Kenneth S K Tung; Cory Teuscher
Journal:  Cell Immunol       Date:  2010       Impact factor: 4.868

Review 7.  Modeling multiple sclerosis in laboratory animals.

Authors:  Bettina Schreiner; Frank L Heppner; Burkhard Becher
Journal:  Semin Immunopathol       Date:  2009-10-03       Impact factor: 9.623

8.  The process of somatic hypermutation increases polyreactivity for central nervous system antigens in primary central nervous system lymphoma.

Authors:  Manuel Montesinos-Rongen; Monica Terrao; Caroline May; Katrin Marcus; Ingmar Blümcke; Martin Hellmich; Ralf Küppers; Anna Brunn; Martina Deckert
Journal:  Haematologica       Date:  2021-03-01       Impact factor: 9.941

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.